- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ARKG
Recent news which mentions ARKG
As stock-market turbulence revs up, this ETF theme has drawn 32% of flows in 2022 so far: ‘This isn’t a flash in the pan’
January 20, 2022
From MarketWatch
3 Bargain Stocks Cathie Wood Loves
January 16, 2022
From Motley Fool
Get ready for the climb. Here’s what history says about stock-market returns during Fed rate-hike cycles.
January 15, 2022
From MarketWatch
From Benzinga
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
From Motley Fool
Pfizer/Beam Deal Highlights In Vivo Potential
January 11, 2022
From ETF Trends
Exactly How I'd Invest $5,000 If I Had to Start From Scratch Today
January 04, 2022
From Motley Fool
3 of Cathie Wood’s Best and Worst Stock Picks of 2021
January 03, 2022
From InvestorPlace
Why Teladoc Health Stock Was Up Nearly 5% Today
December 30, 2021
From Motley Fool
These are the best ETFs and themes to buy in 2022, and its all about yields, says Astoria Advisors
December 30, 2021
From MarketWatch
UiPath Stock Is Worth Believing in Here as Wood Holds Fast
December 30, 2021
From InvestorPlace
A small-cap ETF has surged over 30% in 2021, handily beating the S&P 500. Can it do it again in 2022?
December 23, 2021
From MarketWatch
Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday
December 20, 2021
From Benzinga
$1 trillion in U.S. ETF inflows next year? ‘It’s safe to say that the sun is setting on the mutual-fund era:’ Here’s what’s in store for funds in 2022, say pros
December 16, 2021
From MarketWatch
Is Now a Good Time to Buy Teladoc Stock?
December 16, 2021
From Motley Fool
Unusual Sequencing Could Be Predictive in Coronavirus Fight
December 14, 2021
Tickers
ARKG
From ETF Trends
Is Cathie Wood's Genomic ETF a Buy After Sinking This Year?
December 13, 2021
Tickers
ARKG
From Motley Fool
10 Top Stocks to Watch in Cathie Wood’s New CTRU Transparency ETF
December 08, 2021
From InvestorPlace
The ARK Transparency ETF (CTRU) Starts Trading Today. 9 Things to Know.
December 08, 2021
From InvestorPlace
Omicron Variant Shows Need to Expand Genomics Capabilities
December 06, 2021
Tickers
ARKG
From ETF Trends
ARK Innovation fund falls to lowest level in over a year as Nasdaq Composite sinks toward correction
December 03, 2021
From MarketWatch
From Motley Fool
Bionano Genomics Proves Not Everything Genetic is Gold
December 01, 2021
From InvestorPlace
Has Cathie Wood Lost Her Touch?
November 24, 2021
From Motley Fool
Opportunity Could Be Knocking for Disruptive Healthcare Strategies
November 23, 2021
Tickers
ARKG
From ETF Trends
The anti-Cathie Wood ETF has landed. Here’s how it’s doing so far
November 11, 2021
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.